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Current status and future developments of
contrast-enhanced ultrasound of carotid
atherosclerosis
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B-mode and Doppler ultrasound are commonly used for the evaluation of atherosclerosis in the carotid arteries. Recently,
contrast-enhanced ultrasound (CEUS) has been introduced as a technique to improve the detection of carotid
atherosclerosis and evaluate the presence of intraplaque neovascularization, which is considered a marker of plaque
vulnerability. The present review focuses on the role of CEUS for the assessment of atherosclerosis and plaque instability.
Currently available literature and future developments with CEUS are discussed. (J Vasc Surg 2013;57:539-46.)
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tAccording to the current guidelines,1 carotid endarter-
ectomy is highly beneficial in patients at average or low
surgical risk who experience nondisabling ischemic stroke
or transient ischemic cerebral symptoms and a 70% ste-
nosis present in the ipsilateral internal carotid artery. Ca-
rotid endarterectomy in patients with a high-grade stenosis
but asymptomatic for cerebrovascular disease and in those
with a 50% to 69% stenosis may be beneficial, but the
benefit-to-risk ratio decreases and more individualized
management decisions must be made.1 A risk stratification
method distinguishing patients with stable carotid plaque
from those with unstable plaque could improve selection of
patients for carotid surgery.
The concept of the vulnerable atherosclerotic plaque
was first described for coronary artery disease and relates to
plaques with a thin fibrous cap covering a large lipid ne-
crotic core, and active inflammation, characteristics that
make the plaque at increased risk of rupture.2 Intraplaque
neovascularization is a novel marker of plaque vulnerabil-
ity.2,3 The intraplaque neovessels are leaky due to increased
gap junctions, thus serving as a port of entry for inflamma-
tory cells, lipids, and even red blood cells, which contrib-
utes to plaque growth. Moreover, the neovessels are at
increased risk for rupture, causing intraplaque hemorrhage
and subsequent rapid progression to symptomatic disease.
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http://dx.doi.org/10.1016/j.jvs.2012.07.028he presence of neovascularization in carotid plaques has
een associated with symptomatic cerebrovascular disease.4
B-mode and Doppler ultrasound are widely available
nd are frequently used for evaluation of atherosclerosis in
he carotid arteries.1 Recently, contrast-enhanced ultra-
ound (CEUS) has been introduced for the evaluation of
arotid atherosclerosis and plaque vulnerability by identify-
ng the presence of intraplaque neovascularization.5-19 The
resent review provides a brief overview of the commonly
sed ultrasound techniques for the evaluation of carotid
therosclerosis and subsequently focuses on the role of
EUS for the assessment of carotid atherosclerosis and
laque instability. The promising results of the initial
EUS studies in humans are discussed. Additionally, quan-
ification of CEUS images and future developments, in-
luding molecular imaging are discussed.
ETHODS
Study design. This review included all available orig-
nal studies reporting the use of transcutaneous CEUS for
he evaluation of carotid atherosclerosis, in particular intra-
laque neovascularization. Review articles and animal stud-
es were excluded.
Literature search and data extraction. The online
EDLINE database was searched for literature in June
012 using PubMed (National Center for Biotechnology
nformation, U.S. National Library of Medicine, Bethesda,
d). The search strategy was “carotid,” “contrast-
nhanced,” and “ultrasound.” No time restriction for pub-
ication date was used. All titles and abstracts of the articles
ere evaluated. After exclusion based on the title and
bstract, full articles were evaluated, and articles meeting
he inclusion criteria were identified. In addition, a manual
earch of the reference lists of the identified studies was
erformed, and references were evaluated. Selected studies
ere reviewed and relevant patient characteristics and
EUS findings were registered. Extracted parameters were
he number of included patients, age, gender, studied
opulation, degree of stenosis, proportion of symptomatic
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February 2013540 ten Kate et alpatients, use of quantification of CEUS, and whether his-
tology was used as a reference method.
Statistical analysis. Statistical analysis was performed
using Microsoft Excel 2010 (Microsoft Corporation, Red-
mond, Wash) and SPSS version 15.0 (SPSS, Chicago, Ill).
Continuous variables were reported as mean. Categorical
variables were summarized as percentages. From the
pooled data, summary estimates were calculated.
RESULTS
B-mode ultrasound scan. Based on the B-mode im-
ages, an evaluation can be made whether the plaque is
predominantly echolucent, echogenic, or mixed (hetero-
genic).20 Echolucent plaques are thought to consist of soft
plaque components (lipids, intraplaque hemorrhage),
whereas echogenic plaques contain more hard components
(fibrous tissue, calcifications).21 Consequently, echolucent
plaques are considered to be more at risk of rupture and
thrombus formation. Hence, standard B-mode ultrasound
scan measures can be used to improve prediction of cere-
brovascular events and thus possibly refine the selection for
Fig 1. Evaluation of vascular wall irregularities and intr
(CEUS). Carotid artery ultrasound scan performed in
images (A and D) and B-mode images (B and E) at th
contrast (yellow) and the B-mode (blue) images, allowing
image (A) a small noncalcified plaque of 1.5 mm thick is
(long thin arrows), which is barely noticeable on the B
observed between the lumen contrast and vessel wall. T
ulcerated (arrowhead). The bright regions outside the ves
scattering regions and are constantly present during the
contrast has reached the carotid lumen, the contrast mic
intraplaque neovascularization (D and F, small arrows).
a L9-3 probe, SonoVue contrast agent injected intravencarotid endarterectomy. kContrast-enhanced ultrasound: Current status.
EUS is an enhanced form of ultrasound scan using intra-
enous administration of a microbubble contrast agent.
he contrast agent is an intraluminal tracer and can be used
o obtain angiography-like images of the carotid arteries.
ltrasound scan contrast agents were introduced in clinical
ractice in the early 1990s. The currently approved and
sed agents include SonoVue (Bracco SpA, Milan, Italy),
ptison (GE Healthcare, Princeton, NJ), Definity (Lan-
heus Medical Imaging, N. Billerica, Mass), and Levovist
Schering AG, Berlin, Germany). The contrast agents con-
ist of microbubbles (approximately 1-8 m), generally
lled with a perfluorinated gas that has a low solubility, and
tabilized with a phospholipid or protein shell to improve
irculation time. Microbubble contrast agents are intravas-
ular tracers that, because of their size, cannot leave the
ntravascular compartment. The microbubble shell is elim-
nated from the body through the reticuloendothelial sys-
em when the gas is exhaled. Contraindications for micro-
ubble contrast agents are unstable angina, acute cardiac
ailure, acute endocarditis, known right-to-left shunts, and
ue neovascularization by contrast-enhanced ultrasound
de-by-side contrast mode, acquiring the contrast only
e time. C and F, present an overlay image of both the
tter delineation of the plaque. In the contrast-enhanced
nt in the near wall, proximally to the carotid bifurcation
e image (B). In the overlay image (C), a void can be
minal plaque surface appears irregular and is probably
men (thick arrows) are saturation artifacts caused by high
ination. Lower panels: approximately 10 seconds after
bles have entered the atherosclerotic plaque indicating
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Volume 57, Number 2 ten Kate et al 541bubble contrast agents have been administrated in millions
of patients and are safe; side effects are extremely rare.22
For clinical application, microbubble contrast agents
have been registered for tissue perfusion imaging and car-
diac chamber border enhancement. None of the contrast
agents has been registered for imaging of carotid intra-
plaque neovascularization. However, the 2011 updated
guideline on nonhepatic applications of CEUS by the Eu-
ropean Federation of Societies for Ultrasound in Medicine
and Biology, recommends the use of CEUS for the differ-
entiation between total carotid occlusion and residual flow
in tight stenosis, the improvement of lumen delineation in
technically difficult carotid arteries, and for the evaluation
of carotid plaque neovascularization.23 Previous studies by
Ferrer et al24 and Droste et al25 have demonstrated that
CEUS has a high diagnostic accuracy for the detection of
carotid artery occlusion and assessment of carotid artery
stenosis. These studies have demonstrated that CEUS find-
Fig 2. Identification of intraplaque neovascularization b
B-mode ultrasound (A), and CEUS (B-D) acquired at
present (small arrows) in the proximal part and distal p
identifiable by the shadowing (B-D: arrowheads). The hi
arrow are saturation artifacts. Panel (B) was acquired 0.5
contrast given. Contrast enhancement can be observed in
after the flash, the intraluminal contrast has been repleni
(large arrow). Panel (D)was acquired 6 seconds after the
arrow) indicating the presence of intraplaque neovasculaings were in good agreement with the results from digital bubtraction angiography and/or surgery, and also in pa-
ients with poor nonenhanced examination conditions.
Most commercially available ultrasound systems pro-
ide specific pulse sequences (eg, amplitude modulation or
ulse inversion) that retrieve nonlinearities at low acoustic
ower, which are only exhibited by microbubbles.26 These
echniques enable the suppression of tissue in the image
nd allow the specific identification of individual micro-
ubbles. Microbubble contrast agents enhance the arterial
umen, improving the delineation of the lumen, and con-
equently the detection of atherosclerotic plaques and ves-
el wall irregularities (Fig 1).18,27 The capability of ultra-
ound scans to detect individual microbubbles passing
hough the capillary system allows direct visualization of
ntraplaque neovascularization. Because the microbubbles
re strict intravascular tracers, their presence in plaque
epresents the presence of an intraplaque neovessel (Figs 1
nd 2). The identification of individual neovessels cannot
trast-enhanced ultrasound (CEUS) scan. Carotid artery
e consecutive time points. Atherosclerotic plaques are
f the bulbus. The distal plaque contains a calcification,
nhanced regions (B-D) on the left and right side of the
nds before a high mechanical index flash to destroy the
laque (large arrow). Panel (C)was acquired 1.5 seconds
quickly, while the plaque enhancement has disappeared
nd shows the contrast microbubbles in the plaque (large
on (image acquisition described in Fig 1 legend).y con
thre
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February 2013542 ten Kate et aldalities (eg, magnetic resonance imaging is capable of mak-
ing estimations about the amount of intraplaque vascular-
ization based on contrast diffusion28). This has been
supported by in vivo studies in animal models of atheroscle-
rosis, showing an increase in plaque echogeneity after con-
trast infusion and confirming the presence of neovascular-
ization with histology.29
How to perform CEUS. Carotid CEUS can be rela-
tively straightforward, implemented in the routine carotid
ultrasound scan acquisition protocol. After a patient has
been referred for a clinically indicated carotid ultrasound
examination, informed consent should be obtained for the
off-label use of the microbubble contrast agent.30 Subse-
quently, a peripheral venous access catheter is placed. After
acquisition of the standard carotid ultrasound scan images,
the contrast presets of the ultrasound system are selected.
These contrast presets are available in nearly all currently
used vascular ultrasound systems. The presets use an ultra-
sound pulse sequence with a low mechanical index to avoid
destruction of the microbubbles. After injection of contrast
agent followed by a saline flush, high quality CEUS images
can be obtained. After a few minutes, the contrast is elim-
inated, the ultrasound signal intensity becomes weaker, and
administration of the contrast agent can be repeated.
Assessment of intraplaque neovascularization with
CEUS. The literature search yielded 163 articles (Fig 3).
After review, exclusion, and cross-referencing, a total of 15
observational studies were included in the review (Table I).
These 15 studies included a total of 802 patients (69%men,
mean age 66 years). The majority of the patients were
asymptomatic for transient ischemic attack (TIA) or stroke
Table I. Summary of studies on carotid contrast-enhanced
neovascularization in humans
Author Year Study type
Feinstein5 2006 Case report
Vicenzini et al6 2007 Observational
Shah et al7 2007 Observational
Coli et al8 2008 Observational
Huang et al9 2008 Observational
Magnoni et al10 2009 Observational
Papaioannou et al11 2009 Case report
Xiong et al12 2009 Observational
Giannoni et al13 2009 Observational
Staub et al14 2010 Observational
Owen et al15 2010 Observational
Staub et al16 2011 Observational
Shalhoub et al17 2011 Observational
Clevert et al18 2011 Observational
Hoogi et al19 2011 Observational
Summary estimate
dB, Decibel; GSM, gray scale median; IMT, intima-media thickness; NA, no(88%). Feinstein5 was the first to report on the role of rEUS of the carotid arteries in humans to identify the vasa
asorum in vivo. In his 2006 review on carotid ultrasound,
case report was presented demonstrating the identifica-
ion of the vasa vasorum by CEUS and regression of the
asa vasorum 8 months after initiation of statin therapy. In
his report, a visual qualitative evaluation of the vasa vaso-
163 articles
36 review articles excluded
127 articles
122 articles
5 animal studies excluded
articles reviewed and
cross-referencing
107 articles excluded15 articles 
included
ig 3. Flow chart of the literature search and study selection. The
nitial search yielded 163 eligible studies, of which 36 review
rticles and 5 animal studies were excluded. The remaining 122
tudies were evaluated, and after cross-referencing, a total of 15
rticles were included in the review.
asound (CEUS) for the detection of intraplaque
Population/inclusion criteria
No. of
patients
Diabetes 1
Asymptomatic carotid stenosis 23
Significant carotid stenosis before surgery 15
Carotid stenosis before surgery (n  17) or
asymptomatic carotid plaque (n  15)
32
Carotid plaque 63
Significant carotid stenosis (n  25) or no
plaques (n  15)
25
15
Acute coronary syndrome 1
Carotid plaque thickness 2 mm 104
Severe carotid stenosis before surgery 73
Clinical indication for duplex ultrasound scan 147
Carotid plaque causing 30% stenosis 37
Clinical indication for duplex ultrasound scan
and 1 plaque
175
Carotid stenosis before surgery 31
Clinical indication for duplex ultrasound and
1 plaque
33
Carotid stenosis before surgery 27
802
lable; TIA, transient ischemic attack.ultrum was provided and, although no histologic conforma-
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others.
Six studies, including a total of 95 patients, provided
histologic validation of the CEUS images by carotid end-
arterectomy; a summary of these studies is provided in
Table II. It was shown that plaque with a higher amount of
contrast enhancement had a significantly increased density
of small diameter (20-30 m) microvessels in the corre-
sponding region on histology.8,13 No association has been
found between plaque echolucency and vessel density.8
Histologic staining for specific vascular (CD31, CD34,
hemosiderin, and von Willebrand factor) and angiogenic
markers (vascular endothelial growth factor) showed a cor-
relation between intraplaque contrast enhancement and
Table I. Continued.
Mean
age, years Male % Atherosclerosis
S
(str
53 100 Stenosis 50%
70 69 Stenosis 30%
NA 59 Stenosis 60%
70 84 Stenosis 30%
59 67 Plaque thickness 3.1  1.6 mm
71
65
67
80
Stenosis 50%
IMT 1 mm
73 100 Stenosis 50%
63 80 Plaque thickness 2 mm
67 66 Stenosis 70%
64 61 Any plaque
70 73 Stenosis 30%
67 65 Any plaque
71 77 NA
61 61 NA
68 70 Stenosis 70%
66 69
Table II. Summary of the studies comparing carotid intra
(CEUS) scan with histopathological analysis of the plaque
Author Year
Cases with
histology
Vicenzini et al6 2007 1 Histolo
Shah et al7 2007 17 Spearm
Coli et al8 2008 17 Good c
Giannoni et al13 2009 9 Histolo
plaqu
Shalhoub et al17 2011 29 Signific
imm
Hoogi et al19 2011 22 Intrapl
(r2 
Summary estimate 95
CEUS, Contrast-enhanced ultrasound scan.the amount of staining.7,13,19 Thus, contrast enhancement tas shown to correlate with the presence and degree of
ntraplaque neovascularization. A major limitation of the
urrently available studies (Table II) on the relation be-
ween CEUS findings and histologic examination of the
laques after surgery is the poor description of the diagnos-
ic accuracy of CEUS for the assessment of intraplaque
eovascularization. Authors of future studies on this topic
re encouraged to report at least a cross tabulation of the
EUS findings and histology results, with the sensitivity
nd specificity of the test, and a measure of statistical
ncertainty. Moreover, it should be clear how indetermi-
ate, or missing results, and outliers were handled.
Several B-mode ultrasound scan-derived plaque char-
cteristics have been investigated in association with con-
matic
TIA) % Quantification Histology
0 None No
0 None Yes
3 Visual scoring Yes
9 Visual scoring Yes
A Arrival time, time to peak, enhanced
intensity (dB)
No
A
0
Periadventitial B-flow thickness (mm) No
0 Plaque gray-scale (GSM) No
4 Signal enhancement (dB) No
2 Visual scoring Yes
2 None No
3 Late phase enhancement No
7 Visual scoring No
2 Late phase enhancement Yes
A None No
0 Automatic quantification Yes
2
e neovascularization on contrast-enhanced ultrasound
surgery
Histologic findings
nfirmed the CEUS findings
nk correlation of 0.68 between CEUS and histology
ation between CEUS and histology
nfirmed the presence of vascularization in all symptomatic
sistent with the presence of contrast-enhancement on CEUS
orrelation between late phase CEUS and CD68
ositivity (r  .466; P  .011)
neovascularization on CEUS correlated well with histopathology
P  .01)ympto
oke or
3
1
N
N
3
1
1
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1
5
N
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contrast enhancement.16 Characterizing the plaques by
their echolucency has shown that the majority of plaques
characterized as soft or mixed plaques contained vascular-
ization (94% and 73%, respectively), whereas hard and
calcified plaques seem to lack vascularization.6,9,18 Histo-
logic studies are needed to confirm these findings, because
calcification in hard plaques may hinder the CEUS evalua-
tion of intraplaque neovascularization due to acoustic shad-
owing, leading to false-negative results. The echogenicity
was shown to have an inverse but weak correlation to
plaque vascularization (P.199, P .001).16 Vicenzini
et al6 identified plaque with an ulceration in the luminal
border, and observed that every ulceration had an intra-
plaque vessel present underneath the ulceration. The clin-
ical relevance of this observation deserves further investiga-
tion.
Magnoni et al10 combined contrast ultrasound scan
with B-flow imaging to evaluate the presence of adventitial
vasa vasorum in atherosclerotic (stenosis 50%) and
healthy (intima-media thickness 1.0 mm) vessels of pa-
tients matched for gender, age, and clinical features. B-flow
imaging is a non-Doppler technique that provides informa-
tion on blood flow during gray scale ultrasound scan by
displaying flowing intravascular echo-signals. It differs from
power Doppler imaging, a technique using the Doppler
effect, which is a shift in the frequency of the reflected
ultrasound from that of the initial ultrasound pulse. A
peri-adventitial B-flow signal was detected in all patients.
However, the thickness of the B-flow signal was signifi-
cantly higher in patients with carotid atherosclerosis
(1.10  0.11 mm vs 0.80  0.06 mm; P  .0001).10
Four studies evaluated the difference in contrast en-
hancement between patients symptomatic and asymptom-
atic for cardiovascular diseases. Patients with cerebrovascu-
lar symptoms (TIA or stroke) were shown to have
significantly higher contrast enhancement compared to
asymptomatic patients with a similar plaque thickness
(13.9  6.4 dB vs 8.8  5.2 dB; P  .001).12,13 Staub et
al14 investigated the association between CEUS findings
and cardiovascular disease (peripheral artery disease, coro-
nary artery disease, myocardial infarction, or cerebrovascu-
lar disease, including TIA and stroke) and events (myocar-
dial infarction, TIA, or stroke). It was shown that the
presence of an intraluminal plaque was significantly associ-
ated with cardiovascular disease (odds ratio, 4.7; 95% con-
fidence interval, 1.6-13.8), whereas intraplaque neovascu-
larization was associated with a history of cardiovascular
events (odds ratio, 4.0; 95% confidence interval, 1.3-12.6).
These findings support the concept that intraplaque neo-
vascularization is a sign of plaque vulnerability.14 Prospec-
tive follow-up studies have been initiated to further eluci-
date this issue.
Owen et al15 investigated the in vivo value of late
phase-contrast enhancement (6 minutes after contrast in-
jection) as a marker for damaged endothelium and plaque
inflammation. In vitro studies have demonstrated that un-
targeted microbubbles are both phagocytosed by mono- vytes and directly adhere to damaged endothelium.31,32
he retention of microbubbles in a plaque might thus
ndicate the presence of inflammatory cells adhering to the
essel wall and endothelial damage. Owen et al15 reported
significant increase in contrast enhancement 6 minutes
fter contrast injection in symptomatic patients, compared
o asymptomatic patients. Hence, late phase-contrast en-
ancement might have the potential to identify plaque
nflammation and endothelial damage in vivo. In a second
tudy, it was shown that late phase enhancement correlates
ith biological features of inflammation and angiogenesis
n histology.17
Quantification. Quantification methods to analyze
ltrasound images are under development to further im-
rove the accuracy of interpretation and to decrease inter-
eader variation. The majority of the previously discussed
tudies used a qualitative scale to visually score the presence
nd amount of intraplaque neovascularization.6-8,12-14
hese scales are easily implemented and already show sig-
ificant differences in contrast enhancement between
ymptomatic and asymptomatic patient groups.12-14
uantitative measurement of the contrast enhancement
hould further improve the reproducibility and observer
ariability.
Most quantitative techniques currently used are based
n the evaluation of signal intensity increase after contrast
nfusion and show significant differences between symp-
omatic and asymptomatic patient groups.11,12,15 How-
ver, the accuracy and reproducibility of these methods
eed further evaluation. The use of B-flow imaging as
roposed by Magnoni et al10 is an interesting technique to
uantitatively evaluate the adventitial vasa vasorum in the
essel wall. Histopathological studies have demonstrated
hat intraplaque neovascularization sprouts from these ad-
entitial vasa vasorum. Clearly, further studies are desired
o evaluate the exact role of B-flow imaging for this pur-
ose.
Hoogi et al19 showed promising results with a more
ophisticated quantification technique. They calculated the
atio of the neovascularized plaque area to the total plaque
rea and reconstructed different routes microbubbles travel
hrough the plaque with an automated algorithm. A highly
ignificant relationship was found between the neovascular-
zation to plaque area ratio on CEUS and histology (R2 
7905; P  .01), making this a promising tool for quanti-
cation of neovascularization.
Limitations of CEUS. The current commercially
vailable ultrasound systems are equipped with 2D trans-
ucers for carotid imaging. The use of 2D data is subject to
perator dependency and out of plane probe motion. Sev-
ral producers of ultrasound equipment are currently de-
eloping vascular 3D matrix probes. The implementation
f 3D CEUS will allow acquisition of full volume informa-
ion of carotid lumen and plaque, including intraplaque
eovascularization (Fig 4). The 3D carotid ultrasound scan
ill probably also improve interobserver and intraobserver
ariability.
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Volume 57, Number 2 ten Kate et al 545A recently recognized limitation of CEUS is the pseu-
doenhancement artifact.33 This artifact is caused by nonlin-
ear propagation of ultrasound waves through the micro-
bubble contrast agent, leading to pseudoenhancement
visible in the far wall (the vessel wall furthest from the
probe) at locations where no contrast agent is present.
Misidentification of pseudoenhancement may lead to false-
positive results. New ultrasound pulse sequences are being
developed to suppress the pseudoenhancement artifact and
are expected to become commercially available in the near
future.
Future developments in CEUS. Developments in
targeted contrast agents present a prospective for molec-
ular CEUS imaging of intraplaque neovascularization.
By using molecular imaging, one would be able to not
only identify the presence of intraplaque neovasculariza-
tion but also evaluate the angiogenic activity in the
plaque. Studies using targeted microbubbles have shown
the possibility to identify cellular adhesion molecules and
receptors associated with angiogenesis in atherosclerotic
animal models.34 The first human study evaluating vas-
cular endothelial growth factor receptor targeted micro-
bubbles has recently been performed in patients with
prostate cancer, showing promising results for identifi-
cation of active angiogenesis (http://clinicaltrials.gov;
Fig 4. Contrast-enhanced 3D ultrasound scan using vo
strating the transversal (B), sagittal (C), and coronal pla
artery (QLAB; Philips Healthcare, Best, The Netherland
artery, (1) carotid bifurcation, (2) proximal internal, (3) a
branches from the external carotid artery and descends tstudy no: NCT01253213).35ONCLUSIONS
CEUS can be relatively easily incorporated into a stan-
ard carotid ultrasound protocol to improve the evaluation
f plaque morphology and assess intraplaque neovascular-
zation. Identification of an unstable vascularized carotid
laque using CEUS could refine the selection of patients
onsidered for carotid endarterectomy.
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